Inside Industry Secrets: Breaking the Academic Bubble

​Following a landmark launch year, Nucleate Australia’s Sydney Chapter returns for our first event of 2026. This evening is dedicated to one of the most critical transitions in the life science journey: the leap from academia to industry.

​Join us for a high-impact panel discussion featuring industry experts:

• ​Prof Konstantinos Konstantopoulos, William H. Schwarz Professor of Chemical and Biomolecular Engineering, Johns Hopkins University

• ​Brian Gilmartin, Director of Regulatory Affairs, Biointelect

• ​Laura Wimberger PhD, Investment Associate, Proto Axiom

• ​Stuart Fraser PhD, Founder and CEO, Culturon

​📍 Level 2, Merewether Building H04, The University of Sydney, NSW 2006
📅 10th of March 2026
🕔 Start: 5:30 – 8:00 PM

​We will pull back the curtain on the "academic bubble" to explore the diverse career pathways available to PhDs and researchers. Whether you are looking to join a high-growth startup, navigate the regulatory maze, or transition into VC, this event provides the roadmap for your post-PhD career.

​​​Whether you are after a casual conversation, brainstorming ideas, or seriously planning your next startup, join us to connect with peers, mentors, and leaders in biotech, business and entrepreneurship.
​​---------------------------------------------------------------
​About the Host:​

​​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.

​​We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!

​​Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma 

​​Philanthropic Support: Lyda Hill Philanthropies

​​Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout

​​In-Kind Support: AcademicLabs, Lens.org, SynBioBeta